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ABSTRACT  
Tuberculosis (TB) is an infectious disease caused by the Mycobacterium tuberculosis (M. tuberculosis) complex, resposible  for health problems 
in developing countries. In Africa, various medicinal plants are traditionally used to treat  TB.  The aim of this study is to carry out the 
phytochemical screening, to evaluate the antimycobacterial activity of the crude extracts of three medicinal plants present i n Cameroon 
(Zingiber officinale, Vitellaria paradoxa and Alstonia boonei) and the acute toxicity of hydroethanolic extract of Vitellaria paradoxa. The 
phytochemical screening was obtained by hydroethanolic extraction  and decoction. Inhibitory parameters of antimycobacterial activities were 
determined using the microplate alamar blue assay against M. tuberculosis H37Rv (ATCC 27294) and on one M. tuberculosis clinical strain. The 
crude extract with the best antimycobacterial activity was used for the acute toxicity assessment according to the OECD protocol. The results of 
the phytochemical screening revealed the presence of triterpenes and steroids in all the extracts, whereas  phenols were only present in the 
decoction of Alstonia boonei. All extracts tested showed antimycobacterial activities. The hydroethanolic extract of V. paradoxa  presented the 
best antimycobacterial activity with MICs of 78.13 and 625 μg/mL and MBCs of 78.13 and 2500 μg/mL respectively on M. tuberculosis H37Rv 
and on M. tuberculosis clinical strain. The results of the acute toxicity evaluation of V. paradoxa  showed a lethal dose 50  greater than 5000 
mg/kg compared to control. The antimycobacterial activity of all the plant extracts used in this study justifies the traditional use of these 
medicinal plants on the treatment of  TB. 
Keywords: Zingiber officinale, Vitellaria paradoxa, Alstonia boonei, Phytochemical screening, Antimycobacterial activity, Acute toxicity. 
 
Article Info: Received 29 Nov 2019;     Review Completed 10 Jan 2020;     Accepted 17 Jan 2020;     Available online 15 Feb 2020 
Cite this article as: 
Assam Assam JP, Yumsu Tcham MF, Moni NEDF, Betote DPH,  Fossi TC,  Penlap BV, Phytochemical screening, 
Antimycobacterial activity of three medicinal Cameroonians plants and Acute toxicity of hydroethanolic extract of 
Vitellaria paradoxa, Journal of Drug Delivery and Therapeutics. 2020; 10(1-s):96-104  
http://dx.doi.org/10.22270/jddt.v10i1-s.3848                                                                                      
*Address for Correspondence:  
Assam Assam Jean Paul, Department of Microbiology, Faculty of Science, University of Yaounde I P.O. Box 812, Yaounde, Cameroon 
 
 
1. INTRODUCTION 
Mycobacterium tuberculosis (M. tuberculosis), the 
leading causative agent of tuberculosis (TB) is responsible 
for the morbidity and mortality of a large population 
worldwide 1. It is widespread in poor countries, with more 
than 80% of cases occurring in Asia and Africa 2. TB does not 
exhibit any symptom of disease except when impairment of 
immunity arises due to malnutrition, diabetes, malignancy 
and AIDS 3; however, about 10% of healthy individuals may 
develop active TB in their life time due to genetic factors. 
The ability of TB to resist drugs and the influence of HIV  
epidemy has made the disease remain a devastating global 
public health problem 4. In 2016, an estimated number of 
10.4 million new TB infections were reported, on which 90% 
were adults, 65% were male and 10% were people living 
with HIV  5. This disease is responsible for approximately 
two million deaths annually 6. The alarming rise of multi-
drug-resistant (MDR), extensively drug-resistant (XDR) and 
currently, totally drug resistant (TDR) M. tuberculosis 
strains, which are difficult to control with the currently 
available essential antitubercular drugs on the market, and 
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the increased incidence of TB associated with viral infections 
such as HIV, have recently complicated the 
chemotherapeutics of  TB 7. Indeed, the side effects of 
current anti-TB drugs used in long course in combination for 
the treatment of disease, lead to poor patient compliance 
and thus promoting the emmergence of resistant strains 8. 
As a result, one of the current lines of research is the 
investigation of new natural compound endowed with 
antimycobaterial properties and non toxic, which can permit 
to fight effectively both susceptible and resistant strains of 
M. tuberculosis. Natural products of plant biodiversity have 
received considerable attention as potential anti-TB agents 
since they are  proven templates for the development of new 
molecules against  TB. Many antitubercular compounds that 
may prove to be useful leads for TB drug discovery have 
been derived from medicinal plants 9. 
In Africa, many plants are used against various 
respiratory tract infections, including: Zingiber officinale 
(Zingiberaceae) 10, Vitellaria paradoxa (Sapotaceae)10,11,12 
and Alstonia boonei (Apocynaceae) 13,14 . Numerous scientific 
studies have shown that these plants have various biological 
properties 15, 16, 17, but very few have investigated the 
antimycobacterial properties of Zingiber officinale and 
Vitellaria paradoxa and so far to the best of our knowledge, 
no study has been  carried out on extracts of Alstonia boonei. 
Ginger (Z. officinale) in Cameroon is traditionally used 
in the villages of the Central Region for the treatment of 
respiratory diseases 18 and in the Littoral region, for the 
treatment of infectious disorders, such as pulmonary 
infections including TB 14. In Niger, it is used in the 
treatment of TB and other respiratory diseases 10. Shea tree 
(V. paradoxa) is traditionally used in Cameroon against 
intestinal worms in children 19, while in Niger it is used for 
the treatment of TB and other respiratory diseases 10 and in 
the states of Bauchi and Ogun in Nigeria for the treatment of  
TB  11, 12. As for “devil  tree ” (A. boonei) 20, it is traditionally 
used for the treatment of endocrino-metabolic, neurological, 
cardiovascular and infectious disorders such as pulmonary 
infections and  TB 14. In Kisangani, Congo (Zaire), it is used 
against throat diseases and  TB 13. However in traditional 
medicine, the method of preparation commonly used for the 
use of these plants is the decoction 18. The purpose of the 
present study, however, is to carry out the phytochemical 
screening, determine the antimycobacterial activity and 
evaluate the acute toxicity of crude extracts obtained by 
hydroethanolic  extraction (30° ethanol) and decoction of 
Zingiber officinale, Vitellaria paradoxa and Alstonia boonei. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
  Rifampicin (Rif) were obtained from Sigma-Aldrich 
(St. Quentin Fallavier, France). Stock solutions at 1000 
μg/mL were filter sterilized and stored at -20°C. Working 
solutions were prepared at four times the final higher 
concentration in Middlebrook 7H9 supplemented with 2% 
glycerol, 10% OADC (oleic acid, albumin, dextrose, and 
catalase) and 0.05% (vol/vol) Tween 40 (Sigma). Alamar 
blue dye 0.01% (weight/volume) from Sigma-Aldrich (St. 
Quentin Fallavier, France) was prepared and sterilized by 
filtration, and stored at 4°C for up to 1 week. Kit SGM Italia 
were also obtained from Sigma-Aldrich. 
2.2. Collection and extraction of plant materials 
  Fresh rhizomes of Z. officinale were  purchased in 
August 2017 from  three Markets (Mvog-beti, Mokolo and 
Acacia), Yaoundé, Center Region, Cameroon. The stem bark 
of V. paradoxa and A. boonei were harvested respectively in 
September 2017 from Tcholliré village, North Region, 
Cameroon and in August 2017 from Kala village, Center 
Region, Cameroon. Botanical identification of the plants was 
performed at the Cameroon National Herbarium, where the 
voucher specimens were conserved under the reference 
numbers 14757/SRF/Cam (Z. officinale), 14591/SRF/Cam 
(V. paradoxa) and 1943/SRFK (A. boonei). 
  The fresh rhizomes of Z. officinale after being 
purchased in the different markets were washed with tap 
water and then cut and dried at room temperature away 
from light. The barks of V. paradoxa and A. boonei after 
harvest were directly cut and dried at room temperature 
away from light. Once well dried, they were finely  crushed  
manually  using  mortar  and  pestle to obtain a powder. The 
extracts were obtained by two common extraction 
techniques, maceration and decoction. 
According to maceration, The extracts were 
prepared as earlier described by combination of Prakash et 
al. (2005) 21 and Sourabie et al. (2012) 22 with slight 
modifications. One hundred and fifty grams of each powder 
were soaked with 750 mL of 30% ethanol in ratio 1:5 (w/v) 
and mixed intermittently for 48h. This process was repeated 
three times and subsequently, the suspension was filtered 
using Whatman No.1 filter paper. The filtrate obtained was 
concentrated using a rotary evaporator at 79°C, the residue 
was lyophilized and stored at room temperature.  
  The extracts obtained by decoction were prepared 
as earlier described by Sourabie et al. (2012) 22 with slight 
modifications. A total of 1000 mL of boiling distilled water 
was poured into 150 g of plant powder under constant 
shaking with magnetic stirrer for 15 min. This operation was 
repeated twice and at the end of the extraction, it was 
filtered through nylon mesh followed by Whatman filter 
paper No.1. The filtrate was then concentrated under 
reduced pressure on rotary evaporator at 40°C, the residue 
was lyophilized and stored at room temperature. 
2.3 Experimental animals 
  Albino Wistar rats aged 8 to 12 weeks old, 
weighing between 125 g to 169 g were obtained from the 
animal house, of the Department of Animal Biology and 
Physiology, University of Yaounde I, Cameroon. They  were  
allowed to acclimatize for a period of 2 weeks. They were 
maintained in clean metabolic cage-sand, placed in a well-
ventilated room conditions with a temperature of 26ºC to 
28ºC, photoperiods of 12 hours light and 12 hours darkness; 
humidity of 40% to 60% (Rong et al., 2009) 23. 
2.4 Phytochemical screening 
The various plant extracts were screened for plant 
metabolites using the lyophilized materials. It was carried 
out in accordance with standard methods  described by 
Harbone (1998) 24 and Evans (2000) 25. These metabolites 
include alcaloid, phenols, polyphenols, tanins, saponins, 
flavonoids, triterpens, steroids, anthocyanins and 
anthraquinones. 
2.5 In vitro antimycobacterial assay 
2.5.1 Bacterial strains and growth conditions 
The studied microbial species included two strains 
of mycobacteria, namely, a drug-susceptible strain of M. 
tuberculosis H37Rv (ATCC 27294) and one M. tuberculosis 
clinical strain (MTCS). They were maintained on 
Lowenstein-Jensen (LJ) slopes and cultured on Middlebrook 
7H9 broth supplemented. Cultures were grown aerobically 
on supplemented broth medium at 37°C. 
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2.5.2 Microplate alamar blue assay (MABA) 
All samples were tested against M. tuberculosis 
using the microplate dilution method 26. The MIC and MBC of 
all samples against M. tuberculosis strains were tested using 
the MABA according to Collins and Franzblau, 1997 27. 
Briefly, representative colonies of M. tuberculosis from 
Lowenstein-Jensen (LJ) slope were suspended in 1 mL 
distilled water and the turbidity was adjusted to match 
McFarland tube No.1 (107 CFU/mL) and further diluted to 
1:25 in Middlebrook 7H9 broth supplemented and  used as 
inoculums. One hundred microliters of Middlebrook 7H9 
broth supplemented was dispensed in each well of a sterile 
flat-bottom 96-well plate, and serial twofold dilutions of the 
crude extracts and each positive control drug were prepared 
directly in the plate. One hundred microliters of inoculum 
was added to each well. A growth control and a sterile 
control were also included for each mycobacterial strain. 
Sterile water was added to all perimeter wells to avoid 
evaporation during  incubation. The plates were covered, 
sealed in plastic bags, and incubated at 37°C under a normal 
atmosphere. After incubation for about 7 days, 20 µL of 
Alamar blue solution were added to the wells. The plates 
were re-incubated overnight at the same temperature. A 
color change from blue to pink indicated bacterial growth. 
All experiments were carried out in triplicate. The minimum 
inhibitory concentration (MIC) was defined as the lowest 
concentration of the crude extract or positive control drug 
that prevented this change in color and the minimum 
bactericidal concentration (MBC) corresponded to the 
minimum concentration of extract that did not produce a 
shift in cultures re-incubated in fresh medium. The 
classification of the extracts was made by calculating the 
ratio MBC/MIC as described by Carbonelle et al. (1987) 28 
and Gatsing et al. (2006) 29 for which, an antimicrobial 
substance is considered bactericidal when the ratio 
MBC/MIC ≤ 4 and bacteriostatic when the ratio MBC/MIC 
˃4. 
2.6 Toxicity test 
2.6.1 Acute toxicity study 
Acute toxicity study was performed according to 
the procedures outlined by the Organization for Economic 
Co-operation and Development guidelines 423 30. Twelve 
Wistar female albino rats were used for this study. The rats 
were randomly divided into 3 groups of 4 animals each, with 
the first group as the control. The hydroethanolic extract of 
V. paradoxa was administered to rats in groups 2 and 3 in 
single oral doses of 2000 mg/kg and 5000 mg/kg body 
weight respectively, by intra gastric gavage using oral 
cannula. The control group (Group 1) received an equal 
volume of distilled water. Observations of toxic symptoms 
were made and recorded within the first hour, four hours 
and subsequently for 24 hours after administration of the 
extract. Behavioral parameters and mortality were also 
monitored closely for 14 days. Lethal dose in 50 %  of  the  
total  population  (LD50)  was interpolated using OECD 
method 30. 
2.6.2 Body weight 
The rats in all the groups were weighed using a 
sensitive balance, before starting the administration of 
extract, every two days during the observation period and 
once on the day of sacrifice. Doses of the extract 
administered were adjusted accordingly. 
2.6.3 Relative organ weight 
On day 14 of the observation period, all the animals 
were euthanised by exsanguination under chloroform 
anesthesia. The rats were later sacrificed through lumbar 
dislocation. Different organs namely the kidneys, liver, 
spleen, lungs and heart were carefully dissected out and 
weighed in grams (absolute organ weight). The relative 
organ weight of each animal was then calculated as follows: 
                     
                        
                                   
      
2.6.4 Biochemical analyses 
Blood samples were collected from the animals 
through cardiac puncture, into clean and dry tubes. The 
blood collected was allowed to clot and then centrifuged at 
5000 rpm for 10 minutes. The serum was separated  and 
kept frozen at -4ºC until required for analysis (Aniagu et al., 
2005) 23. The separated clear sera collected were used for 
the biochemical assays of AST, ALT and Creatinin using SGM 
Italia reagent kit. 
2.7 Statistical analysis 
The experimental results were expressed as the 
Mean ± S.E.M. Statistical significant difference in parameters 
amongst groups was determined by One way ANOVA 
followed by Tukey’s multiple range test using GraphPad 
version 7.0. P<0.05 was considered to be significant. 
3 RESULTS AND DISCUSSION 
  The extraction yields and the physical properties of 
the various extracts obtained by hydroethanol maceration 
and decoction are recorded in Table I. These yields ranging 
from 5.97 to 13.63% respectively for V. paradoxa bark and Z. 
officinale rhizomes for maceration. Meanwhile, in decoction 
they ranging from 2.36 to 27.77% respectively for A.boonei 
bark and Z. officinale rhizomes. For two (02) of the three 
(03) samples, the extraction yield obtained by decoction is 
greater than that obtained by hydroethanol maceration for a 
similar sample. These results corroborate those of 
Mahmoudi et al. (2013) 31 and Lehout and Laib (2015) 32, 
who made the same observation in their work. However, for  
A.boonei bark, the extraction yield by hydroethanol 
maceration was higher than that of the decoction. This 
reduction in the extraction yield of  A. boonei by decoction 
would probably be due to the denaturation of certain 
thermosensitive compounds by heat, as presented by the 
work of Kémajou et al. (2012) 33, who evaluated the 
influence of drying temperature on the active ingredients 
(total alkaloids) of  A. boonei; where they found that the  
total alkaloids content of the bark extract gradually 
decreases as  the drying temperature increases. In addition, 
rhizomes of Z. officinale  had the best extraction yield, both 
in hydroethanol maceration and decoction. This observation 
could be explained by the fact that rhizomes of  Z. officinale 
contain more active compounds. It is in the same light that 
the work of Mariangela et al. (2015) 34, demonstrated that in 
addition to the pulp of rhizomes of Z. officinale, the skin of 
this latter also contains active compounds and that it 
contains more non-polar compounds and even twice as 
many polyphenolic compounds as the pulp. In fact, according 
to Bruneton (1999) 35 the extraction yields of the plants are 
different depending on the species of the plant, the organ 
and the extraction solvent. The determination of the 
extraction yield makes it possible to assess the total extract 
of each species and organ of the plant thus making it 
possible to estimate the quantity of the part of the plant to 
be harvested if necessary to allow the rational use of these 
plant species 36 .
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Table I: Extraction yield and physical properties of the extracts 
Extraction 
types 
Extraction 
solvents 
Extract types Extraction yield 
(%) 
Physical properties of extracts obtained 
Color State 
 
Extraction by 
Maceration 
 
Hydroethanol 
(70/30, v/v) 
M Z. o 13,63 Yellow Liquid 
M V. p 5,97 Brick red Liquid 
M A. b 10,97 Pale yellow Liquid 
 
Extraction by 
Decoction 
 
Distilled water 
D Z. o 27,77 Yellow Viscous 
D V. p 10,36 Brick red Liquid 
D A. b 2,36 Yellow Liquid 
Legend: M = Macerat; D = Decoction; Z. o = Zingiber officinale ; V. p = Vitellaria paradoxa ; A. b = Alstonia boonei 
  
The results of the phytochemical screening of the extracts 
are shown in Table II. From this phytochemical test, it is 
seen that all the extracts contain  triterpenes and  steroids, 
and that among these extracts, only the decoction of A. 
boonei contains phenols. This could be explained by the fact 
that during extraction, the heat produced during the 
decoction would have caused the breaking of certain bonds, 
thus causing the formation of phenols. This is in line with 
results obtained by Ross et al. (2011) 37 who reported that 
under the effect of high temperature, there is partial 
degradation of lignin, leading to the release of phenolic acid 
derivatives.  Amongst other things, saponins would probably 
be sensitive to heat because their presence is considerably 
reduced, or even absent in decoction compared to 
maceration in all samples.  Alkaloids, saponins, flavonoids 
and steroids present in Z. officinale extract have also been 
reported in the work of Kobo et al. (2014) 38. Amongst 
others, Amari (2016) 39 in his work highlighted  the presence 
of flavonoids, triterpenes and the absence of anthraquinones 
in  Z. officinale extract as presented by the results obtained. 
In addition, Ogudo et al. (2014)  40 also reported in their 
work the presence of alkaloids, flavonoids and the absence 
of phenols as observed in the present work, but the absence 
of saponins and anthraquinones in their extract does not 
agree with the results here obtained. On the other hand, the 
absence of tannins in the extract presented here runs 
counter to the results obtained by all of them. However, their 
study  did not indicate the presence of  polyphenols and 
anthocyanins which were rather present in this study. This 
test permitted us to reveal the presence alkaloids, saponins, 
flavonoids, triterpenes and steroids in A. boonei extract. 
These results concords with those of Voukeng et al. (2016) 41 
and Opoku and Akoto. (2015) 42, who used the bark and 
roots of A. boonei respectively. Nevertheless, the presence of 
anthraquinones reported by these works  are contrary to 
those of Opoku and Akoto. (2015) 42. Owolabi et al. (2014) 43 
also reported the presence of alkaloids, saponins, flavonoids, 
anthraquinones and the absence of tannins in A. boonei 
leaves  just as those obtained with the bark in this study. 
None of the previous studies tested for presence of phenols 
and anthocyanins which were however absent and present 
respectively in this study. The presence of alkaloids, tannins, 
saponins and the absence of phenols evidenced by this 
phytochemical test in V. paradoxa bark extract coroborates 
with the results obtained by El-Mahmood et al. (2008) 44, 
while the anthraquinones present in this extract were 
absent. These latter did not search  for polyphenols, 
flavonoids, triterpenes, steroids and anthocyanins, which 
were all present in this study. In addition, Ndukwe et al. 
(2007) 45 noted the absence of flavonoids in their extracts, 
which is contrary to that of this work and the presence of 
alkaloids, saponins and steroids, which is similar to the 
results obtained in this study.  However, Fodouop et al. 
(2017) 46 showed the presence of alkaloids, polyphenols, 
tannins and flavonoids in the leave extract of V. paradoxa 
similar to that in this study. On the other hand, the presence 
of phenols and the absence of saponins, triterpenes, steroids, 
anthocyanins and anthraquinones reported in their results 
do not agree with those presented here. The difference in 
chemical composition of the extracts presented by the 
results of this work and others can be explained by the 
nature of the solvent, the part of the plant used,  the 
technique of extraction and  the nature of the soil  on which 
the plant has grown, as reported by several authors such as 
Bruneton (1999) 47 and Nyegue (2006) 48, who have 
demonstrated that the chemical composition of plant 
Essential oils can vary depending on the climate and the 
nature of the soil. In addition, Hudaib et al. (2002) 49 also 
indicated that theperiod of collection,  method of 
conservation,  genetic factors and vegetative cycle of the 
plant can also influence the variability of the chemical 
composition.
 
Table II: Phytochemical Screening 
Families of  secondary 
metabolites 
 
Crudes extracts 
Hydroehanolic Maceration Decoction 
MZ. o MV. p MA. b DZ. o DV. p DA. b 
Alkaloids ++ + +++ +/- - + 
Phenols - - - - - ++ 
Polyphenols + + + ++ + +/- 
Tanins - ++ - - ++ +/- 
Saponins ++ + + - - - 
Flavonoids +/- ++ + - ++ +/- 
Triterpenes + + + + + + 
Steroids + + + + + + 
Anthocyanins + ++ ++ + ++ + 
Anthraquinones - + + +/- + + 
Legend : - : absent;  +/- : presence as a trace;  + : weak presence ;   ++ : average presence ; +++ : high presence 
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The antimycobacterial tests on M. tuberculosis H37Rv and 
MTCS made it possible to determine the  minimal inhibitory 
concentration (MIC) and the minimal bactericidal 
concentration (MBC) and the MBC/MIC ratio on these latter 
and grouped respectively in Tables III and IV. On  M. 
tuberculosis H37Rv, the best MIC of 78.13 μg/ mL also 
representing the best MBC was obtained with the bark of V. 
paradoxa both with maceration and decoction. The 
classification of these extracts shows that, only the extract of 
A. boonei obtained by hydroethanolic maceration is 
bacteriostatic. However, the MIC of 1250 μg/mL obtained 
with Z. officinale extract on M. tuberculosis H37Rv  is eight 
times lower than that reported by Nguta et al. (2016) 50 on 
the same strain that was 10,000 μg/mL. Furthermore, Ballo 
(2013) 19 in his work with V. paradoxa leaves obtained via a 
70° ethanol maceration of  this latter, a MIC of 125 μg/mL on 
H37Rv. The present study with the bark of this latter by 
maceration with ethanol 30°  revealed a MIC of 78.13 μg/mL 
on the same strain. On the other hand, on the MTCS, the best 
MIC (625 μg/mL) and  MBC (2500 μg/mL) was obtained with 
the hydroethanolic extract of V. paradoxa. All these extracts 
were bactericidal on the MTCS, except the decoction of Z. 
officinale which could not be classified considering that its 
MBC could not be determined (it did not belong to the range 
of the  concentrations). The significant difference between 
the results obtained in this study  and those of the other  
studies could be explained on the one hand by the difference 
in the chemical composition of plant organs, which is a 
function of different factors such as climate, soil type 47,48 , 
the  period of collection, the method of conservation, genetic 
factors and the vegetative cycle of the plant 49 and  on the 
other hand the nature of the solvent used Paiva et al. (2010) 
51 showed that, depending on the polarity of the extraction 
solvents, the metabolites present in the extracts  differ in 
their polarity and structure and hence, the antimicrobial  
activities of the compounds extracted from plants changes  
with a change in  structure. It is in this sense that Cowan 
(1999) 52 alluded to the example between catechol and 
pyrogallol, both of which are hydroxylated phenols that have 
been shown to be toxic to microorganisms. Catechol has two 
hydroxyl groups and pyrogallol has three hydroxyl groups. 
The site (s) and number of groups on the  aromatic ring are 
thought to be related to their relative toxicity to 
microorganisms, with evidence that increased hydroxylation 
leads to increased toxicity. In addition, some authors have 
found that more strongly oxidized phenols are more 
inhibitory52. It also appears from the results of this work 
that, in general, the hydroethanolic extracts were more 
active than those obtained by decoction  on the two strains. 
Nevertheless, despite the fact that extracts obtained by 
decoction generally contain with more chemical compounds  
due to their high yield, they are still less active than 
hydroethanolic extracts. This could be explained by the 
difference in concentration of active ingredients in plant 
extracts 53. Indeed, decoction despite their high yield contain 
a low concentration of active ingredients with 
antimycobacterial properties, compared to extracts obtained 
by hydroethanolic maceration, which for their low yield 
contain a large  number of compounds with 
antimycobacterial properties. This low decoction activity can 
also be explained by the fact that the antimycobacterial 
activity of the compounds in these extracts would be masked 
by other compounds present in the extract 54 . According to 
Kuete (2010) 55 the activity of plant extracts can be classified 
on the basis of MICs obtained in antimicrobial tests. Thus, it 
can be: significant (MIC <100 μg/mL), moderate (100 <MIC 
<625 μg/mL) or low (MIC> 625 μg/mL). In this rank of idea, 
among the hydroethanolic extracts, the activity was 
significant for the bark of V. paradoxa (MIC = 78.13 μg/mL), 
moderate for the bark of A. boonei (MIC = 156 μg/mL) and 
low for rhizomes of Z. officinale (MIC = 1250 μg/mL) on M. 
tuberculosis H37Rv. In addition, with decocts on M. 
tuberculosis H37Rv, the activity was significant for the bark of 
V. paradoxa (MIC = 78.13 μg/mL), low for the bark  of A. 
boonei and rhizomes of Z. officinale (respectively at MICs of 
2500 and 5000 μg/mL). On the other hand, on the clinical 
strain of M. tuberculosis, the activity of hydroethanolic 
extracts was moderate for bark of V. paradoxa (MIC = 625 
μg/mL) and low for all other extracts (with MICs of 2500 and 
5000 μg/mL respectively for A. boonei and Z. officinale in 
hydroethanolic maceration while in decoction, MICs were 
1250, 5000 and 10,000 μg/mL respectively for V. paradoxa, 
A. boonei and Z. officinale). Seen these results, this clinical 
isolate would probably be resistant. Indeed, by observing 
MIC obtained on this isolate with the reference anti-TB drug 
(Rifampicin), which was 3.91 μg/mL this result goes in the 
same line as that of Gordien et al. (2009) 56 who in their 
study obtained a MIC greater to 3.29 μg/mL on a Rifampicin-
resistant isolate. This seems to confirm the resistant 
character of this clinical isolate and in particular resistant to 
Rifampicin. Amongst others , all decocts had a weak activity 
on the clinical strain. The antimycobacterial  activities of 
these extracts could be explained by the presence of 
alkaloids, phenols, polyphenols, flavonoids, quinones, 
terpenoids and steroids (Brent, 2003) 57. However, Kuete et 
al. (2010) 55 showed the inhibitory activity of flavonoids of 
Dorstenia barteri on M. tuberculosis, while Gordien et al. 
(2009) 56 revealed the antimycobacterial activities of 
terpenoids Juniperus communis L on M. tuberculosis. In 
addition, Kuete et al. (2009) 58 presented the inhibitory 
activity of naphthoquinones from two species of Diospyros, 
Diospyros canaliculata and Diospyros crassiflora on M. 
tuberculosis. As a result, anthraquinones belonging to the 
same family as naphthoquinones and having the same 
functional group would probably also have a role in the 
antimycobacterial potential of the extracts where they are 
present. The antimycobacterial activity exerted by rhizome 
extracts of Z. officinale is probably due to the gingerol 
contained in these rhizomes 59 . Amongst others, Moustafa et 
al. (2016) 17 reported the presence of three phenolic 
compounds quercetin, catechin and epicatechin in the bark 
of V. paradoxa while the work of Raju et al. (2015)  60 showed 
the inhibitory activity of quercetin and epicatechin on M. 
tuberculosis. This could explain the antimycobacterial 
activity of V. paradoxa bark extracts in this study. So far, to 
the best of our knowledge, no scientific study has evaluated 
the antimycobacterial properties of A. boonei, however 
Adotey et al. (2012) 61 recalled in their works that bark of A. 
boonei were isolated from alkaloids, the major ones being 
echitamine and echitamidine and triterpenoids such as 
lupeol, ursolic acid and β-amyrin. These metabolites are thus 
likely to be responsible for the antimycobacterial activity of 
this latter.
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Table III: Activity levels (MIC and MBC), MBC/MIC ratio and extracts classification against M. tuberculosis H37Rv 
 
Extracts 
  Activity levels against M. tuberculosis  H37Rv 
(µg/mL) 
Ratio 
MBC/MIC 
Classification of 
extracts 
CMI CMB 
H
y
d
ro
é
th
a
n
o
li
c 
M
a
ce
ra
ti
o
n
 MZ. o 1250 5000 4 Bactericidal 
MV. p 78.13 78.13 1 Bactericidal 
MA. b 156.25 2500 16 Bacteriostatic 
D
e
co
ct
io
n
 DZ. o 5000 5000 1 Bactericidal 
DV. p 78.13 78.13 1 Bactericidal 
DA. b 2500 5000 2 Bactericidal 
Rifampicin 0.49 0.49 1 Bactericidal 
 
Table IV: Activity levels (MIC and MBC), MBC/MIC ratio and extracts classification against the MTCS 
 
Extracts 
  Activity levels against  MTCS (µg/mL) Ratio 
MBC/MIC 
Classification of 
extracts 
CMI CMB 
H
y
d
ro
é
th
a
n
o
li
c 
M
a
ce
ra
ti
o
n
 
MZ. o 5000 10,000 2 Bactericidal 
MV. p 625 2500 4 Bactericidal 
MA. b 2500 5000 2 Bactericidal 
D
e
co
ct
io
n
 DZ. o 10,000 N.d / / 
DV. p 1250 5000 4 Bactericidal 
DA. b 5000 10,000 2 Bactericidal 
Rifampicin 3.91 3.91 1 Bactericidal 
Legend: N.d = Not determined 
 
The hydroethanolic extract of V. paradoxa  had the 
best antimycobacterial activity on both strains. The results 
of the acute toxicity evaluation of this extract revealed that 
the single administration of the 2000 and 5000 mg/kg doses 
of this extract to healthy female rats caused no evidence of 
apparent toxicity after the first 4 hours. It had no effect on 
the behavior of the animals (mobility, appearance of the 
coat, aspect of the buttocks, eye colors, ...) in comparison 
with the control. In addition, no deaths were noted in the 
experimental groups after 14 days of study. This suggests 
that the lethal dose 50 (LD50) of this extract would be 
greater than 5000 mg/kg and that this latter would be 
classified according to the Globally Harmonized 
Classification System (GHS) to category 5 of low or no toxic 
substances 62. These results are similar to those obtained by 
Mainasara et al. (2016a) 63 who also showed that the LD50 of 
the methanolic extract of V. paradoxa bark was greater than 
5000 mg/kg. Figure 1 illustrates the effects of the 
hydroethanolic extract of V. paradoxa on the weight 
variation of the rats. It shows that animal body weights 
increased exponentially the first two days after treatment, 
then varied irregularly until the fourteenth day for all test 
groups and  sensibly in a regular manner for the normal 
group. However, no significant difference in weight was 
observed between the animals treated with this extract at 
doses of 2000 and 5000 mg/kg and the control. In the same 
rank of idea, Mainasara et al. (2016b) 64 demonstrated by 
their work that the chronic administration  of methanolic 
extract of V. paradoxa at doses up to 400 mg/kg for 30 days 
did not result in a significant variation in the weight of the 
rats during the period of treatment. The relative weight of 
the kidneys, liver, spleen, lungs and heart of the animals that 
received this extract after a 14-day follow-up is summarized 
in Figure 2. No significant difference (p˃0.05) was observed 
between the relative weight of organs of animals treated at 
doses of 2000 and 5000 mg/kg of the hydroethanolic extract 
of V. paradoxa compared to control. Its effect on 
transaminase activity (AST and ALT) and creatinin 
concentration is shown in Table IV. No significant 
differences (p˃0.05) in AST and ALT activities and creatinin 
concentration were observed between animals treated at 
2000 and 5000 mg/kg of this extract compared to control.
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Figure 1 : Effects of  hydroethanolic extract of  V. paradoxa bark on the weight evolution of animals in acute toxicity 
Each point represents the mean ± SEM ; n = 4;  Control : rats treated with distilled water; V. p 2000 mg/kg and V. p 
5000 mg/kg: rats treated with hydroethanolic extract of V. paradoxa respectively at doses of 2000 and 5000 mg/kg. 
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Figure 2 : Relative weight of animal organs that received hydroethanolic extract of V. paradoxa bark 
Each bar represents the mean ± SEM ; n = 4; Control: rats treated with distilled water; V. p 2000 mg/kg and V. p 5000 
mg/kg: rats treated with hydroethanolic extract of V. paradoxa respectively at doses of 2000 and 5000 mg/kg. 
 
Table IV : Effects of hydroethanolic extract of V. paradoxa on transaminase activity (AST and ALT) and creatinin concentration 
       Control V. p 2000 mg/kg V. p 5000 mg/kg 
AST (UI/L) 4,481±0,397 5,471±0,600 3,977±0,563 
ALT (UI/L) 4,263±0,689 5,878±0,333 4,190±0,563 
Créatinin (µmol/L) 95,504±19,500 95,504±10,817 72,158±11,214 
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CONCLUSION 
The results of this study highlights the importance 
to be given to plants,  since they  have many properties 
including antimycobacterial. The antimycobacterial potential 
and the non-toxicity of  hydroethanolic extract (ethanol 30°) 
of the bark of V. paradoxa justifies the traditional use of this 
plant for the treatment of  TB. However, given the fact that  
M. tuberculosis H37Rv was particularly sensitive to extracts of 
V. paradoxa and A. boonei (respectively strong and moderate  
activities), these plants are excellent candidates for the 
search for new molecules that can act against M. tuberculosis 
H37Rv. 
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